Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer-Reference-Cited by-同舟云学术

Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer

Published:2022-06 Issue: Volume:44 Page:101459
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Wang Wenwen,Cai Jing,Wen Jiayi,Li Xinyi,Yu Yingjie,Zhang Lingpu,Han Qing,Wei Zheng,Ma Yujia,Ying Feiquan,Xu Xiaohan,Li Wenhan,Yang Qiang,Sun Si,He Xiaoqi,Cai Liqiong,Xiao Haihua,Wang Zehua

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference60 articles.

1. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

2. A source of hope for platinum-resistant ovarian cancer?

3. Platinum Resistance in Ovarian Cancer: Role of DNA Repair

4. Cisplatin: The first metal based anticancer drug

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD44-hyaluronan mediating endocytosis of iron-platinum alloy nanoparticles induces ferroptotic cell death in mesenchymal-state lung cancer cells with tyrosine kinase inhibitor resistance;Acta Biomaterialia;2024-09

2. Enhancing ovarian cancer treatment with maleimide-modified Pt(IV) prodrug nanoparticles;Materials Today Bio;2024-08

3. Fluorescence‐Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids;Advanced Healthcare Materials;2024-06-03

4. Recent updates in nanoscale delivery systems of platinum(IV) antitumor prodrugs;Coordination Chemistry Reviews;2024-06

5. A platinum(IV)–artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy;MedComm;2024-05-20